pharmacies, third-party tested for purity
Future Microbiol (2020) 15:117383
While it shows potential for promoting tissue repair and reducing inflammation, its premature to label it a cure for chronic conditions without more robust clinical data
Would you be shocked to learn that stem cells can only do their job once redox signaling molecules have first done theirs
HGF/c-Met signaling is a well-established oncogenic pathway: c-Met is amplified or overexpressed in multiple cancers (gastric, lung, renal, hepatocellular) HGF/c-Met activation promotes tumor cell proliferation, survival, invasion, and metastasis c-Met inhibitors are FDA-approved cancer drugs (cabozantinib, crizotinib, capmatinib) A compound that potentiates HGF/c-Met signaling raises theoretical concerns about promoting tumor growth or transformation with chronic use
The 2026 reversal, even if partial, corrects some of that damage